Tepkinly

Tepkinly (Epcoritamab) is a prescription medication used for certain blood cancers. This subcutaneous injection targets CD37-positive cells to support disease management. Always consult a healthcare provider for suitability. Short-term storage guidance may apply.

Tepkinly (Epcoritamab) is prescribed for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It is also used in specific cases of follicular lymphoma. Patients may ask, 'what is Tepkinly used for' when exploring treatment options. This therapy is part of a broader approach to blood cancer care.

Tepkinly (Epcoritamab) works by helping the immune system recognize and attack cancerous cells. Users may notice changes in energy levels or symptom improvement over time. Individual responses vary, and effects are monitored by a healthcare professional. Regular follow-ups are recommended.

Store Tepkinly as directed by a healthcare provider or pharmacist. Keep this medication away from children and pets. Do not use if the packaging is damaged or expired. Report any unusual reactions to a medical professional promptly. Follow local disposal guidelines for unused or expired medication.

Tepkinly may interact with other immune-modulating therapies or live vaccines. Avoid alcohol or herbal supplements unless approved by a doctor. Some medications, like strong CYP inhibitors, could affect how Tepkinly works. Always inform your healthcare provider about all current medications.